Albert A Davis1, Brad Racette1. 1. Department of Neurology (AAD, BR), Washington University School of Medicine, St. Louis, MO; and School of Public Health (BR), University of the Witwatersrand, Johannesburg, South Africa.
Abstract
PURPOSE OF REVIEW: While the distinctive motor symptoms of Parkinson disease (PD) have been described for centuries, cognitive impairment has only recently been recognized as a central feature. Studies have yielded clues to the etiology and natural history of cognitive impairment in PD, but much remains unclear and effective therapies are needed. RECENT FINDINGS: Longitudinal cohort studies demonstrate that almost all patients with PD will develop dementia if they live long enough. New CSF biomarker and genetic studies suggest that it may soon be possible to forecast and track the progression of dementia in PD. Sleep and sleep disturbance appear to be intrinsically linked with PD, although the implications for individual outcomes and opportunities for intervention are unclear. Multidisciplinary treatment approaches incorporating cognitive training may help to improve outcomes. SUMMARY: We review several recent advances in understanding the pathophysiology, genetics, and management of cognitive impairment in PD.
PURPOSE OF REVIEW: While the distinctive motor symptoms of Parkinson disease (PD) have been described for centuries, cognitive impairment has only recently been recognized as a central feature. Studies have yielded clues to the etiology and natural history of cognitive impairment in PD, but much remains unclear and effective therapies are needed. RECENT FINDINGS: Longitudinal cohort studies demonstrate that almost all patients with PD will develop dementia if they live long enough. New CSF biomarker and genetic studies suggest that it may soon be possible to forecast and track the progression of dementia in PD. Sleep and sleep disturbance appear to be intrinsically linked with PD, although the implications for individual outcomes and opportunities for intervention are unclear. Multidisciplinary treatment approaches incorporating cognitive training may help to improve outcomes. SUMMARY: We review several recent advances in understanding the pathophysiology, genetics, and management of cognitive impairment in PD.
Authors: H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold Journal: Neurology Date: 2000-05-23 Impact factor: 9.910
Authors: Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Debby Tsuang; Haley Huston; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian Journal: Mov Disord Date: 2015-08-21 Impact factor: 10.338
Authors: Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan Journal: Lancet Neurol Date: 2013-09-04 Impact factor: 44.182
Authors: Delaram Safarpour; Dylan P Thibault; Cori L DeSanto; Cynthia M Boyd; E Ray Dorsey; Brad A Racette; Allison W Willis Journal: Neurology Date: 2015-07-02 Impact factor: 9.910
Authors: Michael K Scullin; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Donald L Bliwise Journal: Brain Date: 2012-08-20 Impact factor: 13.501
Authors: Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian Journal: JAMA Neurol Date: 2013-02 Impact factor: 18.302
Authors: Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris Journal: Mov Disord Date: 2008-04-30 Impact factor: 10.338
Authors: Cristina Nombela; James B Rowe; Sophie E Winder-Rhodes; Adam Hampshire; Adrian M Owen; David P Breen; Gordon W Duncan; Tien K Khoo; Alison J Yarnall; Michael J Firbank; Patrick F Chinnery; Trevor W Robbins; John T O'Brien; David J Brooks; David J Burn; Roger A Barker Journal: Brain Date: 2014-07-30 Impact factor: 13.501
Authors: Maria I Maraki; Alexandros Hatzimanolis; Niki Mourtzi; Leonidas Stefanis; Mary Yannakoulia; Mary H Kosmidis; Efthimios Dardiotis; Georgios M Hadjigeorgiou; Paraskevi Sakka; Alfredo Ramirez; Benjamin Grenier-Boley; Jean-Charles Lambert; Stefanie Heilmann-Heimbach; Maria Stamelou; Nikolaos Scarmeas; Georgia Xiromerisiou Journal: Front Mol Neurosci Date: 2021-12-21 Impact factor: 5.639
Authors: Teresa Zwierko; Wojciech Jedziniak; Beata Florkiewicz; Piotr Lesiakowski; Marta Śliwiak; Marta Kirkiewicz; Wojciech Lubiński Journal: Int J Environ Res Public Health Date: 2022-02-03 Impact factor: 3.390